<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR18">
 <label>18.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kicska</surname>
    <given-names>GA</given-names>
   </name>
   <name>
    <surname>Long</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>HÃ¶rig</surname>
    <given-names>H</given-names>
   </name>
   <name>
    <surname>Fairchild</surname>
    <given-names>C</given-names>
   </name>
   <name>
    <surname>Tyler</surname>
    <given-names>PC</given-names>
   </name>
   <name>
    <surname>Furneaux</surname>
    <given-names>RH</given-names>
   </name>
   <name>
    <surname>Schramm</surname>
    <given-names>VL</given-names>
   </name>
   <name>
    <surname>Kaufman</surname>
    <given-names>HL</given-names>
   </name>
  </person-group>
  <article-title>Immucillin H, a powerful transition-state analog inhibitor of purine nucleoside phosphorylase, selectively inhibits human T lymphocytes</article-title>
  <source>Proc Natl Acad Sci U S A</source>
  <year>2001</year>
  <volume>98</volume>
  <fpage>4593</fpage>
  <lpage>4598</lpage>
  <pub-id pub-id-type="doi">10.1073/pnas.071050798</pub-id>
  <pub-id pub-id-type="pmid">11287638</pub-id>
 </element-citation>
</ref>
